Bone cement implantation syndrome during joint replacement in oncological patients
Abstract
Methods. We performed a prospective study incidence, risk factors and haemodynamic effects associated with bone cement implantation syndrome (BSIS) at 211 oncological patients undergoing cemented joint replacement: total hip (30), knee (141), ankle (6), femur (9), elbow (3), hemischoulder (22) arthroplasty. The anesthetic technique consisted of superficial general or spinal anesthesia with epidural or conductive analgesia. The cardiovascular changes were determined. Multivariate logistic regression analysis was conducted to determine which clinical variables were predictive of BCIS.
Results. The incidence of BCIS was 7.8% (11/141), 3.3% (1/30), 0% (0/22) among patients undergoing knee, hip and shoulder arthroplasty accordingly; intraoperative mortality was 0% (0/211). Independed patient-related risk factors have been implicated in the genesis of BCIS including old age, body mass index. There were three cases of BCIS during knee arthroplasty with inflated tourniquet.
Conclusion. The cardiovascular indicators during cemented period could significantly increase that means cardiovascular reserves preservation.
About the Authors
R. V. Garyaev
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Moscow
A. V. Sokolovsky
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Moscow
I. A. Rychkov
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Moscow
References
1. Donaldson A.J., Thomson H.E., Harper N.J., Kenny N.W. Bone cement implantation syndrome. Brit. J. Anesth. 2009, v. 102, No. 1, p. 12-22.
2. Coventry M.B., BeckenbaughR.D., NolanD.R., IlstrupD.M. 2,012 total hip arthroplasties: a study of postoperative course and early complications. J. Bone Joint Surg. 1974, v. 56, p. 273-284.
3. Ereth M.H., Weber J.G., Abel M.D. et al. Cemented versus noncemented total hip arthroplasty-embolism, haemodynamics and intrapulmonary shunting. Mayo Clinic Proc. 1992, v. 67, p. 1066-1074.
4. Parvizi J., HollidayA.D., Ereth M.H., Lewallen D.G. Sudden death during primary hip arthroplasty. Clin. Orthop. Relat. Res. 1999, v. 369, p. 39-48.
5. Мамаева Е.Г., Лебединский К.М., Машков В.М. и соавт. Синдром имплантации костного цемента при эндопротезировании тазобедренного сустава. СПб.: СПбМАПО. 2009, 116 с.
6. Byrick R.J., ForbesD., Waddell J.P. A monitored cardiovascular collapse during cemented total knee replacement. Anesthesiology. 1986, v. 65, p. 213-216.
7. Govil P., KakarP.N., Arora D. et al. Bone cement implantation syndrome: a report of four cases. Indian J. Anaesth. 2009, v. 53, No. 2, p. 214-218.
8. Orsini E.C., Richards R.R., Mullen J.M. Fatal fat embolism during cemented total knee arthroplasty: a case report. Can. J. Surg. 1986, v. 29, p. 385-386.
9. Lafont N.D., Kalonji M.K., Barre J. et al. Clinical features and echocardiography of embolism during cemented hip arthroplasty. Can. J. Anesth. 1997, v. 44, p. 112-117.
10. Herrenbruck T., Erickson E.W., Damron T.A., Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin. Orthop. Relat. Res. 2002, v. 395, p. 154-163.
11. Karlsson J., Wendling W., Chen D. et al. Methylmethacrylate monomer produces direct relaxation of vascular smooth muscle in vitro. Acta Anaesthesiol. Scand. 1995, v. 39, p. 685-689.
12. Peebles D.J., Ellis R.H., Stride S.D.K., Simpson B.R.J. Cardiovascular effects of methylmethacrylate cement. Br. Med. J. 1972, v. 1, p. 349-351.
13. McLaughlin R.E., DiFazio C.A., Hakala M. et al. Blood clearance and acute pulmonary toxicity of methylmethacrylate in dogs after simulated arthroplasty and intravenous injection. J. Bone Joint Surg. 1973, v. 55, p. 1621-1628.
14. Modig J., Busch C., Olerud S. et al. Arterial hypotension and hypoxaemia during total hip replacement: the importance of thromboplastic products, fat embolism and acrylic monomers. Acta Anaesthesiol. Scand. 1975, v. 19, p. 28-43.
15. Modig J., Busch C., Waernbaum G. Effects of graded infusion of monomethylmethacrylate on coagulation, blood lipids, respiration and circulation. Clin. Orthop. Relat. Res. 1975, v. 113, p. 187-195.
16. Orsini E.C., ByrickR.J., MullenJ.B.M. et al. Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components the role of intramedullary pressure. J. Bone Joint Surg. 1987, v. 69, p. 822-832.
17. McCaskie A.W., Barnes M.R., Lin E. et al. Cement pressurization during hip replacement. J. Bone Joint Surg. (Br.). 1997, v. 79, p. 379-384.
18. Edmonds C.R., Barbut D., Hager D., Sharrock N.E. Intraoperative cerebral arterial embolisation during total hip arthroplasty. Anesthesiology. 2000, v. 93, p. 315-318.
19. Sevitt S. Fat embolism in patients with fractured hips. Br. Med. J. 1972, v. 2, p. 257-262.
20. Byrick R.J. Cement implantation syndrome: a time limited embolic phenomenon. Can. J. Anaest. 1997, v. 44, No. 2, p. 107-111.
21. Gammer W., Bengtson A., Heideman M. Inhibition of complement activation by high-dose corticosteriods in total hip arthroplasty. Clin. Orthop. Relat. Res. 1998, v. 236, p. 205-209.
22. Wheelwright E.F., Byrick R.J., Wigglesworth D.F. et al. Hypotension during cemented arthroplasty. Relationship to cardiac output and fat embolism. J. Bone Joint Surg. 1993, v. 75, p. 715-723.
23. Hayakawa M., Fujioka Y., Morimoto Y. et al. Pathological evaluation of venous emboli during total hip arthroplasty. Anaesthesia. 2001, v. 56, p. 571-575.
24. Werner L. A response to «Sudden deaths during hip hemiarthroplasty». Anaesthesia. 2003, v. 58, p. 922-923.
25. Lamade W.R., Friedl W., SchmidB., Meeder P.J. Bone cement implantation syndrome. A prospective randomised trial for the use of antihistamine blockade. Arch. Orthop. Trauma Surg. 1995, v. 114, p. 335-339.
26. Mitsuhata H., Saitoh J., Saitoh K. Methylmethacrylate bone cement does not release histamine in patients undergoing prosthetic replacement of femoral head. Br. J. Anaesth. 1994, v. 73, p. 779-781.
Review
For citations:
Garyaev R.V., Sokolovsky A.V., Rychkov I.A. Bone cement implantation syndrome during joint replacement in oncological patients. Bone and soft tissue sarcomas, tumors of the skin. 2015;(1):8-16. (In Russ.)
Views:
240
Email this article 
